Trevi Therapeutics (TRVI) Long-Term Investments (2022)

Trevi Therapeutics' (TRVI) quarterly Long-Term Investments came in at $1.0 million in Q2 2022.

Trevi Therapeutics (TRVI) Long-Term Investments (2022) Analysis & Trends

Trevi Therapeutics' Long-Term Investments history runs 1 years deep, the most recent figure standing at $1.0 million for Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	505,194.89
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	5.75 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	9.79 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Trevi Therapeutics	2.50 Bn	2.50 Bn	-	-

Download Data

Date	Value
Jun 30, 2022	1.00 Mn